Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
18 results
  • Gastric (Stomach) Cancer, Liver Cancer, Cervical Cancer

20-577          Phase I

A First-in-human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients with Intrahepatic Cholangiocarcinoma (ICC) and Other Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Gastric (Stomach) Cancer

17-489          Phase I

A Phase 1 Open-label Dose Escalation and Dose Expansion Study of CGX1321 in Subjects with Advanced Solid Tumors and Phase 1b Study of CGX1321 in Combination with Pembrolizumab in Subjects with Advanced Gastrointestinal Tumors (View details on clinicaltrial.gov)

  • Gastric (Stomach) Cancer, Lung Cancer, Esophageal Cancer, Colorectal Cancer, Breast Cancer, Ovarian Cancer

22-235          Phase I

A Phase 1, Open-Label, Multicenter, Dose Escalation Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of IMM2902 in Patients with HER2-Expressing Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Lung Cancer, Liver Cancer, Esophageal Cancer, Metastatic/Advanced Cancer, Brain Tumors, Metastatic, Gastric (Stomach) Cancer

19-812          Phase I

A Phase 1, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0022, a novel MET/CSF1R/SRC inhibitor, in Patients with Advanced Solid Tumors Harboring Genetic Alterations in MET (View details on clinicaltrial.gov)

  • Bladder Cancer, Liver Cancer, Gastric (Stomach) Cancer, Sarcoma, Pancreatic Cancer, Endometrial Cancer, Esophageal Cancer

20-544          Phase II

A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients with Advanced Solid Tumors Harboring a p53 Y220C Mutation (View details on clinicaltrial.gov)

  • Ovarian Cancer, Endometrial Cancer, Breast Cancer, Gastric (Stomach) Cancer

22-142          Phase II

A Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single Agent and in Combination Therapy for Patients with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Breast Cancer, Pancreatic Cancer, Lung Cancer, Gastric (Stomach) Cancer, Head and Neck Cancer, Esophageal Cancer, Endometrial Cancer, Ovarian Cancer, Cervical Cancer

22-015          Phase I

A Phase 1a/1b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PY159 as a SA and In Combination with Pembrolizumab in Subjects with Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Gastric (Stomach) Cancer, Pancreatic Cancer, Colorectal Cancer

22-129          Phase II

A Phase 1b/2 Study of Agents Targeting the Mitogen-Activated Protein Kinase Pathway in Patients with Advanced Gastrointestinal Malignancies (HERKULES-3) (View details on clinicaltrial.gov)

  • Pancreatic Cancer, Gastric (Stomach) Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer

22-368          Phase II

A Phase 2 Study of VLS-101 in Patients with Solid Tumors (View details on clinicaltrial.gov)

Showing 1 - 10 of 18 results